Trial Condition(s):

Erectile Dysfunction

Study Evaluating the Efficacy and Safety of flexible-dose Vardenafil in subjects with erectile dysfunction

Bayer Identifier:

100497

ClinicalTrials.gov Identifier:

NCT00658177

EudraCT Number:

Not Available

Study Completed

Trial Purpose

Study to investigate the efficacy and safety of Vardenafil

Inclusion Criteria
- Men >/= 18 years of age, with 6 months or longer diagnosis of ED as defined by NIH Consensus statement,
 - History of unresponsiveness to sildenafil
 - Stable sexual relationship for > 6 month.
Exclusion Criteria
- Primary hypoactive sexual desire
 - History of myocardial infarction, stroke or life-threatening arrhythmia within prior 6 month
 - Nitrate therapy
 - Other exclusion criteria apply according to the US Product Information

Trial Summary

Enrollment Goal
463
Trial Dates
black-arrow
Phase
3
Could I receive a placebo?
Yes
Products
Levitra (Vardenafil, BAY38-9456)
Accepts Healthy Volunteers
No

Where to Participate

Locations
Status
LocationsStatus

Trial Design